(Q36647801)

English

Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer

scientific article published on January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

J Schneider

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Pollán

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Tejerina

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Sánchez

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A R Lucas

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

88

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

96-101

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600656

0 references

Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

30 September 2017

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

30 September 2017

Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

30 September 2017

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

28 June 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

28 June 2018

Prognostic importance of the uPa/PAI-1 complex in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

20 September 2018

Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376772

20 September 2018

Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12556966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600656

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36647801&oldid=1517074348"